Natera, Inc.
NTRA
$106.46
-$2.04-1.88%
Headlines
5/19/2024
-
Zolmax
5/19/2024
-
Zolmax
5/18/2024
-
GuruFocus
5/18/2024
-
Tickeron - Stocks
5/18/2024
-
Tickeron - Stocks
5/18/2024
-
Zolmax
5/16/2024
-
Investopedia Headlines
5/16/2024
-
The Online Investor
5/16/2024
-
Ticker Report
5/16/2024
-
Zolmax
5/16/2024
-
Zolmax
5/15/2024
-
Globe Newswire
5/14/2024
-
The Fly
5/14/2024
-
TipRanks Financial Blog
5/14/2024
-
TipRanks Financial Blog
5/14/2024
-
Ticker Report
5/14/2024
-
Ticker Report
5/13/2024
-
Benzinga
5/13/2024
-
The Fly
5/13/2024
-
ETF Channel
5/13/2024
-
Zolmax
5/12/2024
-
Ticker Report
5/12/2024
-
Ticker Report
5/12/2024
-
Simply Wall St
5/12/2024
-
Ticker Report
Filings
Friday, May 10, 2024
Sunday, March 31, 2024
Beginning of August (est)
Price History
Corporate Info
650 980 9190
13011 McCallen Pass
Building A - Suite 100
Austin, TX 78753
Building A - Suite 100
Austin, TX 78753
Business Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal...
more